"Dr Manmohan Singh, soon after becoming the prime minister, had himself carried a small table for us to have tea comfortably at his Safdarjung Lane residence instead of asking his house help," Dr Srinath Reddy, who was the chairperson of the PM's medical panel, recalled.
The list, posted on a website link launched by the US regulator, includes ABB, HSBC, Nokia, Unilever, Cadbury, Total and Siemens among others.
Dr Reddy's Laboratories, the second largest drug maker in the country, would invest about Rs 750 crore.
Take the rediff business quiz and see how much you know about India's pharmaceutical industry.
The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015
Indian drugmaker Dr Reddy's Laboratories said on Thursday it had filed an application with the US Food and Drug Administration to market a generic form of GlaxoSmithKline's anti-nausea drug Zofran.\n\n
Equity market investors would track global trends, foreign fund movement and quarterly earnings in a holiday-shortened week ahead, analysts said. Stock exchanges BSE and NSE will conduct a special Muhurat trading session on Tuesday, October 21.
The combined sales of the branded versions of the products in the US is about $3.5 billion.
A three-member committee, comprising two officials from the Director of Factories and one pharma expert, will probe the gas leak at a production unit of Dr Reddy's Laboratories (DRL). The Director of Factories will appoint a pharma domain expert soon.
8 Member of Parliaments were suspended from Lok Sabha for tearing & throwing papers at the Chair till April 2. Uproar started when Rahul Gandhi was barred from citing former Army Chief, General M M Naravane's memoir on 2020 India-China clash. Rediff.com brings you the details of these MPs who were suspended.
DRL launched four new products in North America during the previous quarter.
Dr Reddy's has offered a price of 0.52 euro in cash for each OctoPlus share.
Maharashtra Deputy Chief Minister Ajit Pawar and four others were killed after their aircraft crashed in Baramati on January 28, 2026. Here are 11 other prominent Indians who died in air crashes.
Dr Reddys Laboratories Ltd has posted a net profit of Rs 931.60 million for the quarter ended December 31, 2002 as compared to a net profit of Rs 1615.30 million in the quarter ended December 31,2001.
Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy's Laboratories alleging that the Indian drug-makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (palbociclib) before expiration of its patent.
Opposition candidate B Sudershan Reddy appeals to MPs to vote with conscience in the upcoming vice presidential polls, urging them to prioritize the spirit of India and parliamentary traditions over party loyalty.
'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.'
Opener Shafali Verma smashed a quickfire half-century as India women thrashed Sri Lanka by seven wickets in the second T20 International in Visakhapatnam on Tuesday.
In November, DRL registered growth of 28 per cent year-on-year (YoY), which was the highest among peers and double that of the industry growth (14.5 per cent).
'The real story of 2025 is that India officially stopped being a 'market of the future' and started acting as the world's primary economic engine.'
India's World Cup winning captains -- Harmanpreet Kaur, Deepika T C and Rohit Sharma -- were honoured by the Reliance Foundation in Mumbai on Monday.
The company has launched only 3 new products during 2015 when compared to 14 launches in 2014
The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.
NDA constituents AIADMK and BJP have started preliminary discussions for the 2026 Tamil Nadu Assembly elections. Key leaders from both parties met to discuss strategies to defeat the DMK government and strengthen their alliance.
Despite being a doctor, Mahendra allegedly did not perform CPR. She was taken to a nearby hospital, where doctors declared her dead on arrival, Muni Reddy alleged. Postmortem and Forensic Science Laboratory (FSL) reports later confirmed the presence of anaesthetic substances in her organs, police said.
'Our problem is not a budget deficit but a trust deficit. We need to trust our institutions and industries to innovate and lead. That is the way forward for India.'
'After Kohli's hundred at Ranchi, the second and third phases vanished in minutes. Nothing was left unsold.'
RSS chief Mohan Bhagwat emphasized the importance of social harmony, environmental responsibility, and national unity, urging people to rise above divisions and work collectively for the betterment of society and the nation.
A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has found.
The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.
Apart from favipiravir and remdesivir, its key Covid-19 products, DRL has already launched nutraceutical products and hand sanitisers during the pandemic.
'One day my neighbour in Denver called me and said, "I think somebody is casing your house. So should I call the cops?"... they were scared that people case your house and then rob it.' 'And I said, "no, no, no. It's just that I am an actress".'
US accounts for a large part of revenue for top Indian pharma companies like Gland Pharma (54 percent), Dr Reddy's (53 per cent), and Aurobindo Pharma (48 per cent).
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.
Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US - their largest export market - have weighed heavily on investor sentiment this year. While the Nifty 50 has gained 6.02 per cent year - to - date (as on September 15), the Nifty Pharma index has declined 5.18 per cent, National Stock Exchange data shows.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances